Vitamin E for children with heart disease and lung infections
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests whether giving vitamin E to children with certain heart conditions and severe lung infections can help them leave the hospital sooner. It may reduce the time your child needs to stay in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 months and 5 years old.
- Your child has a non-cyanotic heart disease (a heart condition that doesn't cause bluish skin).
- Your child currently has a severe lower respiratory tract infection (like pneumonia or bronchitis).
- Your child does not have any other birth defects besides the heart condition.
- Your child does not have a chronic lung disease such as asthma or bronchiectasis.
- Your child is not immunocompromised (does not have a weakened immune system) and has not taken vitamin E in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving vitamin C to children hospitalized with severe pneumonia can help them get better faster and leave the hospital sooner. It may be an option for children who have had pneumonia symptoms for 48 hours or less.
This study aims to improve treatment for children with common illnesses like bronchitis and for those who get sick often, to help them recover faster and stay healthier.
This study tests whether giving vitamin C to children under 2 during corrective heart surgery helps them recover better and have shorter hospital stays. If your child is eligible, they would receive vitamin C as part of their care.
This study looks at how vitamin D levels in the blood relate to how sick children with respiratory infections are while in the intensive care unit. It aims to see if low vitamin D is linked to more severe illness, which could guide future treatment.
This trial uses a safe, non-invasive technique called EIT to monitor heart and lung function in children and young adults with certain heart or lung conditions, compared with healthy volunteers. It may help doctors better understand and manage these conditions.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
Hear when a new Respiratory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.